Covered recipient · General Payments record
SUSAN J VAN DELLEN
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$1,036.55
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $453.58 | 34 |
| Education | $126.98 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $183.69 | 10 |
| Amgen Inc. | $180.50 | 20 |
| Janssen Biotech, Inc. | $132.20 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $51.06 | 2 |
| Kiniksa Pharmaceuticals International, plc | $33.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.80 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106267698 | CMS |
| ABBVIE INC. | $11.22 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106267700 | CMS |
| ABBVIE INC. | $23.49 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106267702 | CMS |
| ABBVIE INC. | $16.42 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106267704 | CMS |
| ABBVIE INC. | $25.24 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106267706 | CMS |
| ABBVIE INC. | $6.39 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106267708 | CMS |
| ABBVIE INC. | $23.87 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106267710 | CMS |
| ABBVIE INC. | $30.16 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106267712 | CMS |
| ABBVIE INC. | $30.70 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106267714 | CMS |
| ABBVIE INC. | $7.40 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106267716 | CMS |
| Amgen Inc. | $5.47 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191163 | CMS |
| Amgen Inc. | $7.82 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191134 | CMS |
| Amgen Inc. | $5.04 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191140 | CMS |
| Amgen Inc. | $5.89 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191144 | CMS |
| Amgen Inc. | $7.74 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191149 | CMS |
| Amgen Inc. | $5.94 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191167 | CMS |
| Amgen Inc. | $3.12 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191171 | CMS |
| Amgen Inc. | $4.58 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117707600 | CMS |
| Amgen Inc. | $10.15 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191153 | CMS |
| Amgen Inc. | $7.28 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191157 | CMS |
| Amgen Inc. | $3.03 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191176 | CMS |
| Amgen Inc. | $21.35 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191179 | CMS |
| Amgen Inc. | $3.83 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191161 | CMS |
| Amgen Inc. | $9.17 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117707602 | CMS |
| Amgen Inc. | $6.16 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191182 | CMS |
| Amgen Inc. | $7.79 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191186 | CMS |
| Amgen Inc. | $32.98 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191189 | CMS |
| Amgen Inc. | $4.32 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117707604 | CMS |
| Amgen Inc. | $5.77 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191194 | CMS |
| Amgen Inc. | $23.07 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191197 | CMS |
| Janssen Biotech, Inc. | $5.22 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078759969 | CMS |
| Janssen Biotech, Inc. | $71.99 | 04/25/2024 | Education | Undisputed | 01/23/2026 | 1078760091 | CMS |
| Janssen Biotech, Inc. | $54.99 | 10/31/2024 | Education | Undisputed | 01/23/2026 | 1078760063 | CMS |
| Kiniksa Pharmaceuticals International, plc | $33.11 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154854999 | CMS |
| Novartis Pharmaceuticals Corporation | $28.30 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087372722 | CMS |
| Novartis Pharmaceuticals Corporation | $22.76 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087372724 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.